Evidence map›Paper›PMID 24649083›Full record

ArticleBiomedical reports2014

Association of genetic variants of the α-kinase 1 gene with myocardial infarction in community-dwelling individuals.

Tetsuo Fujimaki, Hideki Horibe, Mitsutoshi Oguri, Kimihiko Kato, Yoshiji Yamada

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Biomedical reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05997641 (A Double-Blind, Randomized, Placebo-Controlled, First-in-Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Administered DF-003 Following Single), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05997641 phase1active not recruitingnot on this mapstarted 2023, after this paper: background citation

A Double-Blind, Randomized, Placebo-Controlled, First-in-Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Administered DF-003 Following Single (Part 1) and Multiple (Part 2) Ascending Doses in Healthy Subjects

TypeinterventionalSponsorShanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)Ran2023 to 2026Enrolled96ConditionsHealthy, Safety and TolerabilityArmsDF-003, Placebo
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Tetsuo FujimakiDepartment of Cardiovascular Medicine, Inabe General Hospital, Inabe, Mie 5110428, Japan.
Hideki HoribeDepartment of Cardiovascular Medicine, Gifu Prefectural Tajimi Hospital, Tajimi, Gifu 5078522, Japan.
Mitsutoshi OguriDepartment of Cardiology, Japanese Red Cross Nagoya First Hospital, Nagoya, Aichi 4530046, Japan.
Kimihiko KatoMeitoh Hospital, Nagoya, Aichi 4650025, Japan ; Department of Human Functional Genomics, Life Science Research Center, Mie University, Tsu, Mie 5148507, Japan.
Yoshiji YamadaDepartment of Human Functional Genomics, Life Science Research Center, Mie University, Tsu, Mie 5148507, Japan.
Gifu Prefectural Tajimi Hospital · JPMeitetsu Hospital · JPMie University · JPShowa Inan General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously demonstrated that rs2074380 (G→A, Gly870Ser) and rs2074381 (A→G, Asn916Asp) of the α-kinase 1 gene (

Indexed as

coronary heart diseasegenetic epidemiologygeneticsmyocardial infarctionpolymorphism

Identifiers

PMID24649083
PMCPMC3917049
OpenAlexW2051721637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.